home / stock / bmrn / bmrn quote
Last: | $82.17 |
---|---|
Change Percent: | 5.42% |
Open: | $86.26 |
Close: | $82.17 |
High: | $86.78 |
Low: | $81 |
Volume: | 7,884,328 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$82.17 | $86.26 | $82.17 | $86.78 | $81 | 7,884,328 | 04-25-2024 |
$91.2 | $92.69 | $91.2 | $93.015 | $91.005 | 1,575,123 | 04-24-2024 |
$92.06 | $90.03 | $92.06 | $92.215 | $89.93 | 1,297,161 | 04-23-2024 |
$89.49 | $89.46 | $89.49 | $89.8075 | $88.89 | 1,257,361 | 04-22-2024 |
$88.63 | $89.67 | $88.63 | $90.18 | $88.29 | 1,778,647 | 04-19-2024 |
$90.07 | $90.25 | $90.07 | $91.21 | $89.775 | 944,850 | 04-18-2024 |
$90.47 | $91.14 | $90.47 | $91.525 | $90.02 | 1,282,481 | 04-17-2024 |
$90.87 | $90.93 | $90.87 | $91.78 | $90.16 | 1,235,787 | 04-16-2024 |
$91.51 | $92.58 | $91.51 | $93.36 | $90.96 | 1,942,193 | 04-15-2024 |
$92.22 | $91.26 | $92.22 | $93.26 | $91.09 | 2,419,825 | 04-12-2024 |
$91.46 | $90.99 | $91.46 | $91.59 | $89.33 | 2,296,918 | 04-11-2024 |
$90.21 | $88.38 | $90.21 | $90.41 | $87.79 | 2,204,505 | 04-10-2024 |
$88.98 | $87.35 | $88.98 | $89.19 | $87.35 | 1,178,105 | 04-09-2024 |
$87.28 | $87 | $87.28 | $88.11 | $86.95 | 1,344,968 | 04-08-2024 |
$86.95 | $86.46 | $86.95 | $87.228 | $86.01 | 828,855 | 04-05-2024 |
$86.89 | $86.78 | $86.89 | $88.13 | $86.63 | 1,151,883 | 04-04-2024 |
$86.78 | $86.48 | $86.78 | $87.72 | $86.475 | 1,166,479 | 04-03-2024 |
$86.8 | $86.25 | $86.8 | $86.94 | $85.62 | 1,410,588 | 04-02-2024 |
$87.1 | $86.98 | $87.1 | $87.305 | $86.09 | 715,533 | 04-01-2024 |
$87.34 | $88.34 | $87.34 | $88.655 | $86.65 | 1,027,708 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
BioMarin Pharmaceutical Inc. Company Name:
BMRN Stock Symbol:
NASDAQ Market:
BioMarin Reports Record Financial Results for the First Quarter 2024 PR Newswire First Quarter 2024 Total Revenues of $649 Million (+9% Y/Y and +13% at Constant Currency Y/Y); GAAP Diluted Earnings per Share (EPS) of $0.46 (+70% Y/Y) and Non-GAAP Diluted Earnings pe...
Pegasystems Inc. (PEGA) is expected to report $0.2 for Q1 2024 Masco Corporation (MAS) is expected to report $0.87 for Q1 2024 Avery Dennison Corporation (AVY) is expected to report $2.15 for Q1 2024 Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A...
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET PR Newswire SAN RAFAEL, Calif. , April 10, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexand...